Do You Know Your EndoScore?

"One of the top nine medical breakthroughs of 2009. One of the most remarkable innovations that promise to revolutionize how doctors prevent, diagnose and treat common conditions and diseases." Prevention December 2009.

Mayo Clinic study shows simple finger device may help predict future heart attacks and strokes.  Results presented at American College of Cardiology Annual Scientific Session show that a simple, noninvasive finger sensor test is "highly predictive" of a major cardiac event such as a heart attack or stroke for people who are considered at low or moderate risk.

Over 50% of heart attacks in US occur in patients with normal cholesterol, so it is vital to have other more reliable methods of detecting early cardiovascular disease. Medical research has demonstrated that abnormal blood flow in your fingertip indicates impaired blood flow in your coronary arteries even if you have a normal lipid level. This can be easily measured using a relatively new testing procedure known as endothelial peripheral tonometry (EndoPAT).  The test is noninvasive and has been proven to be a useful screening tool for detection of those who are likely to have a heart attack or stroke within the next 5-7 years.

EndoPAT is the only FDA approved device indicated for noninvasive assessment of endothelial dysfunction.  The endothelium is the innermost lining of the artery and is where cardiovascular disease starts and progresses.

"A poor score is a stronger warning than the usual risk factors because it indicates that cardiovascular disease has already begun-but an early stage where you can more easily control your risks," according to Amir Lerman, M.D. cardiologist had Mayo Clinic.

Research from the Mayo Clinic indicates that EndoPAT is able to spot early coronary atherosclerosis. "The presence of endothelial dysfunction in coronary or peripheral vessels constitutes an independent predictor of cardiovascular events. EndoPAT is a noninvasive tool to identify patients during early stages of coronary artery disease". Journal of the American College of Cardiology, 2004.

For more than a decade Endothelial Dysfunction has been recognized by the medical community as the critical junction between risk factors and clinical disease. It is the earliest detectable stage of cardiovascular disease. Furthermore, it is treatable, and unlike the atherosclerotic plaque which it causes, is quite reversible.

The EndoPAT adds an important dimension to cardiovascular prevention by enabling physicians to reliably measure endothelial function and identify pathological cases of endothelial dysfunction at early stages.

EndoPAT testing has been available at this clinic for over five  years.  Schedule an appointment today to know more about how healthy your heart and cardiovascular system are.

How the EndoPAT test is done

Results and explanation with the doctor will be available right after procedure is completed.

For more information on EndoPat www.itamar-medical.com